These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 20658231)
21. The role of 18F-FDG PET and PET/CT in the evaluation of primary cutaneous lymphoma. Qiu L; Tu G; Li J; Chen Y Nucl Med Commun; 2017 Feb; 38(2):106-116. PubMed ID: 27792043 [TBL] [Abstract][Full Text] [Related]
22. The utility of positron emission tomography with and without computed tomography in patients with nonmelanoma skin cancer. Duncan JR; Carr D; Kaffenberger BH J Am Acad Dermatol; 2016 Jul; 75(1):186-96. PubMed ID: 26992283 [TBL] [Abstract][Full Text] [Related]
23. Preliminary discussion on the value of (18)F-FDG PET/CT in the diagnosis and early staging of non-mycosis fungoides/Sézary's syndrome cutaneous malignant lymphomas. Dan S; Qiang G; Shu-Xia W; Chang-Hong L Eur J Radiol; 2015 Jul; 84(7):1293-8. PubMed ID: 25982461 [TBL] [Abstract][Full Text] [Related]
24. Imaging findings of a cutaneous B-cell lymphoma. Vanhoenacker FM; Baten A; Vandeputte V JBR-BTR; 2009; 92(6):285-8. PubMed ID: 20166497 [TBL] [Abstract][Full Text] [Related]
25. Can (18)F-FDG PET/CT predict recurrence in patients with cutaneous malignant melanoma? Kang S; Ahn BC; Hong CM; Song BI; Lee HJ; Jeong SY; Lee SW; Lee J; Lee SJ Nuklearmedizin; 2011; 50(3):116-21. PubMed ID: 21246162 [TBL] [Abstract][Full Text] [Related]
26. 18F-fluorodeoxyglucose positron emission tomography-computed tomography imaging in the management of Merkel cell carcinoma: a single-institution retrospective study. Ibrahim SF; Ahronowitz I; McCalmont TH; Hernandez Pampaloni M; Ryan JL; Yu SS Dermatol Surg; 2013 Sep; 39(9):1323-33. PubMed ID: 23777452 [TBL] [Abstract][Full Text] [Related]
27. Fluorodeoxyglucose PET/CT in subcutaneous sarcoidosis mimicking cutaneous lymphoma. Stokkel MP; van der Hiel B; Olmos RV; Hoefnagel K Eur J Nucl Med Mol Imaging; 2012 May; 39(5):919-20. PubMed ID: 22286771 [No Abstract] [Full Text] [Related]
28. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients. Reinhardt MJ; Joe AY; Jaeger U; Huber A; Matthies A; Bucerius J; Roedel R; Strunk H; Bieber T; Biersack HJ; Tüting T J Clin Oncol; 2006 Mar; 24(7):1178-87. PubMed ID: 16505438 [TBL] [Abstract][Full Text] [Related]
30. Granulomatous slack skin: assessment of disease progression and treatment response using positron emission tomography/computed tomography. Sheng Y; Chen L; Huang Z; Mu Z; Kong J; Luo Y; Yang Q Clin Lymphoma Myeloma; 2009 Dec; 9(6):455-8. PubMed ID: 19951886 [TBL] [Abstract][Full Text] [Related]
31. [Management of cutaneous T-cell lymphomas: Recommendations of the French Cutaneous Lymphoma Group]. Beylot-Barry M; Dereure O; Vergier B; Barete S; Laroche L; Machet L; Delfau-Larue MH; D'Incan M; Grange F; Ortonne N; Merlio JP; Bagot M; Ann Dermatol Venereol; 2010 Oct; 137(10):611-21. PubMed ID: 20932440 [TBL] [Abstract][Full Text] [Related]
32. A 45-year-old man with skin lesions and pleural effusion. Vasudevan V; Nallagatla S; Xiao P; Arjomand F; Khan I Chest; 2010 Dec; 138(6):1512-6. PubMed ID: 21138889 [No Abstract] [Full Text] [Related]
33. Role of (18)F-fluorodeoxyglucose positron emission tomography imaging in the management of primary cutaneous lymphomas. Spaccarelli N; Gharavi M; Saboury B; Cheng G; Rook AH; Alavi A Hell J Nucl Med; 2014; 17(2):78-84. PubMed ID: 24997076 [TBL] [Abstract][Full Text] [Related]
35. A rare localised nasal CD30 Nhu QM; Du EZ; Kiyani A; Frenette CT BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29103006 [TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Willemze R; Dreyling M; Ann Oncol; 2009 May; 20 Suppl 4():115-8. PubMed ID: 19454428 [No Abstract] [Full Text] [Related]
37. Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma. Falk MS; Truitt AK; Coakley FV; Kashani-Sabet M; Hawkins RA; Franc B Nucl Med Commun; 2007 Apr; 28(4):273-80. PubMed ID: 17325590 [TBL] [Abstract][Full Text] [Related]
38. Multimodality approach of perioperative 18F-FDG PET/CT imaging, intraoperative 18F-FDG handheld gamma probe detection, and intraoperative ultrasound for tumor localization and verification of resection of all sites of hypermetabolic activity in a case of occult recurrent metastatic melanoma. Povoski SP; Hall NC; Martin EW; Walker MJ World J Surg Oncol; 2008 Jan; 6():1. PubMed ID: 18186915 [TBL] [Abstract][Full Text] [Related]
39. [Malignant lymphoma of the skin]. Kerl H; Volkenandt M; Cerroni L Hautarzt; 1994 Jun; 45(6):421-43; quiz 441-2. PubMed ID: 8071078 [No Abstract] [Full Text] [Related]